Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Alterity Therapeutics (PK) (PRNAF)

Alterity Therapeutics Ltd (PK)
Date:
Sort by:
 Showing the most relevant articles for your search:USOTC:PRNAF
DateTimeSourceHeadlineSymbolCompany
28/02/202512:59Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
28/02/202512:01Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
24/02/202511:08Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
19/02/202511:56Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
18/02/202513:13Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
18/02/202512:59Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
10/02/202512:25Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
10/02/202512:17Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
28/01/202511:33Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
24/01/202513:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
22/01/202513:02Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
21/01/202511:35Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
31/12/202413:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
31/10/202412:48Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
23/10/202412:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
15/10/202412:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
04/10/202410:26Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
02/10/202412:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
30/09/202410:20Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
26/09/202420:40Edgar (US Regulatory)Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
26/09/202420:33Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
26/09/202420:32Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
26/09/202420:30Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
20/09/202412:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
03/09/202410:03Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
01/08/202411:06Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
24/07/202412:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
19/07/202410:31Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
19/07/202410:22Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
18/07/202412:00Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]USOTC:PRNAFAlterity Therapeutics Ltd (PK)
 Showing the most relevant articles for your search:USOTC:PRNAF